MAP2K7 and non-small cell lung carcinoma: The results of the present study on patients’ derived ex-vivo NSCLC cultures, showing positive anti-tumor immune response induced by the triple combination of Ido-1, PD-L1 and MEK- inhibition, encourage further research in this setting, especially in model with mesenchymal and immune-resistant features.